EGFR and non-small cell lung carcinoma: Additionally, the Cobas EGFR Mutation Test v2 is an FDA-approved liquid biopsy test designed for non-small cell lung cancer (NSCLC) patients, focusing on identifying mutations in the epidermal growth factor receptor (EGFR) gene [17].